The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
Izdano u: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
Glavni autori: | Unterberg, Matthias (Autor), Rahmel, Tim (Autor), Köhler, Thomas (Autor), Henzler, Dietrich (Autor), Schwier, Elke (Autor) |
Format: | Članak |
Jezik: | English |
Izdano: |
2022
|
Teme: | |
Online pristup: | https://doi.org/10.1186/s12871-021-01547-8 |
Povezana djela: | In:
BMC Anesthesiology |
Similar Items
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
od: Kirchner, Carmen, i dr.
Izdano: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
od: Köhler, Thomas, i dr.
Izdano: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
od: Grautoff, Steffen
Izdano: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
od: Köhler, Thomas, i dr.
Izdano: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
od: Schwier, Elke, i dr.
Izdano: (2021)